Renal Cell Cancer Presented with Leptomeningeal Carcinomatosis Effectively Treated with Sorafenib

Publisher： Karger

E-ISSN： 2296-5262|30|8-9|450-451

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.8-9, 2007-09, pp. : 450-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 340-347

Karger

Access to resources Recommend Favorite

Reduction in Circulating Tumor Cell Count following Therapy with nab®-Paclitaxel plus Carboplatin in a Patient with Leptomeningeal Carcinomatosis from Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-01 ,pp. : 56-61

Karger

Access to resources Recommend Favorite

Pulmonary Lymphangitic Carcinomatosis due to Renal Cell Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-05 ,pp. : 246-252

Karger

Access to resources Recommend Favorite

Isolated Leptomeningeal Carcinomatosis (Carcinomatous Meningitis) after Taxane-Induced Major Remission in Patients with Advanced Breast Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 6-15

Karger

Access to resources Recommend Favorite

Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer

By  

Oncology, Vol. 80, Iss. 1-2, 2011-05 ,pp. : 34-41

Karger

Access to resources Recommend Favorite